Current status and problems in the diagnosis and treatment of premenstrual syndrome and premenstrual dysphoric disorder from the perspective of obstetricians and gynecologists in Japan. Issue 5 (23rd February 2023)

• Record Type: Journal Article
• Authors: Yoshimi, Kana; Inoue, Fumi; Odai, Tamami; Shirato, Nahoko; Watanabe, Zen; Otsubo, Tempei; Terauchi, Masakazu; Takeda, Takashi
• Is Part Of: Journal of obstetrics and gynaecology research. Volume 49:Issue 5(2023)
• Page Start: 1375
• Page End: 1382
• Publication Date: 2023-02-23
• Subjects: diagnostic criteria -- oral contraceptive pills -- premenstrual dysphoric disorder -- premenstrual syndrome -- selective serotonin reuptake inhibitors; Gynecology -- Periodicals; Obstetrics -- Periodicals; 618.1005
• DOI: 10.1111/jog.15618
• Languages: English
• ISSNs: 1341-8076

Abstract

Abstract: Aim: To investigate the current status and problems in the diagnosis and treatment of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) from the perspective of obstetricians and gynecologists (OB/GYNs) in Japan, the Japanese Society of Obstetrics and Gynecology (JSOG) conducted a national‐wide survey. Methods: An email survey was sent to all JSOG members (16 732) and a web‐based survey was conducted using a Google form between September and November 2021. The current status and problems in PMS/PMDD diagnosis and treatment were surveyed in this cross‐sectional study. Results: In total, 1312 respondents (7.8% of all JSOG members) completed the questionnaire. In terms of diagnoses and treatment, OB/GYN was preferred over psychiatrist for PMS (91.4% vs. 45%); however, no differences were noted for PMDD (76.1% vs. 73.7%). A total of 1267 (96.6%) respondents engaged in routine PMS/PMDD treatment. Regarding the general diagnosis procedure, 84.4% respondents answered "only a vague medical interview, " 8.4% kept a two‐cycle symptom diary, and 10.3% used a screening questionnaire. The most commonly used medication was oral contraceptive pills (OCPs) (98.1%), followed by the Kampo, traditional Japanese herbal medicines, Kamishoyosan (73.6%). Concerning first‐line drugs for treatment, OCPs were the most common (76.8%), followed by Kampo medicine (19.5%); selective serotonin reuptake inhibitors (SSRIs) were less frequently used (2.6%). Regarding first‐line drugs among OCPs, 65.1% respondents reported drospirenone‐ethinylestradriol use. Conclusions: This study indicates that only a few OB/GYNs practicing PMS/PMDD in Japan use a prospective diary, which is an essential diagnostic criterion for PMS/PMDD. Regarding treatment, SSRIs were used less frequently.